Generic placeholder image

Current Molecular Medicine

Author(s): E. Niederberger, C. V. Moser, K. L. Kynast and G. Geisslinger

DOI: 10.2174/1566524011313070004

DownloadDownload PDF Flyer Cite As
The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs

Page: [1089 - 1097] Pages: 9

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

IκB kinase epsilon (IKKε) and TANK-binding kinase 1 (TBK1) are two non-canonical IKKs which are involved in interferon regulatory factor (IRF) as well as nuclear factor kappaB (NF-κB) signaling cascades. Both kinases have already been linked to the pathophysiology of several diseases and therefore been suggested as potential promising targets for the development of therapeutic drugs. In this review, we summarize the roles of IKKε and TBK1 in different diseases and outline therapeutic options for modulation of these kinases.

Keywords: Cancer, IKKε, inflammation, interferon regulatory factor, NF-κB, TBK1.